基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Marks is an Associate Professor of Internal Medicine, received his undergraduate and graduate medical education at the University of New South Wales in Sydney, Australia (1970-1976), trained in Internal Medicine, Clinical Immunology and Pathology from 1977-1986 and was a post-doctoral Research Fellow in the Department of Pathology at the University of Michigan from 1987-1990 before his appointment in the Division of Rheumatology. Dr. Marks is Board certified in both Internal Medicine and Rheumatology, and maintains his original certification in Clinical Immunology and in Pathology. Dr. Marks’s research program is focused on vascular biology. Most recently, Dr. Marks has become interested in the targeting of the microvasculature by hemorrhagic fever viruses, and has been investigating mechanisms that one of these viruses (dengue virus) uses to bind to and infect target cells, including vascular endothelial cells. Dr. Marks research is currently supported by a VA Merit Award. Dr. Marks maintains a strong interest in clinical care and Fellow education, including an interest in the teaching and quantitative evaluation of the Core competencies
Research Interests
Papers共 16 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jonathon W Homeister,Aron D Thall, Bronia Petryniak,Petr Malý,Clare E Rogers,Peter L Smith,Robert J Kelly, Kevin M Gersten,Sanaz W Askari,Guiying Cheng, Glennda Smithson,Rory M Marks,
Immunityno. 1 (2001): 115-126
Elizabeth J. Hindmarsh,Rory M. Marks
Cited23Views0Bibtex
23
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn